Drug firm Alembic Pharmaceuticals today said the US health regulator has granted orphan drug designation to its associate company Rhizen Pharmaceuticals SAs RP6530 used for treatment of cancer. The US Food and Drug Administration (USFDA) has granted orphan drug designation for Tenalisib (RP6530) for the treatment of patients with peripheral T-cell lymphoma (PTCL), Alembic Pharmaceuticals said in a BSE filing. The USFDA grants orphan drug designation to a drug or biological product intended to treat a rare disease in the United States. "A number of incentives are provided for an orphan-drug such as 7-year marketing exclusivity, tax credits for clinical development costs, exemption/waiver of application fees and assistance from FDA Office of Orphan Products Development (OOPD) during the process
Crypto Tales by CoinSwitch Kuber, a new series where our host, Jatin Sapru will meet some of the experts, the gurus, the pioneers, of the Indian Cryptocurrency universe. In this episode, Jatin meets Sayali Rai & Niyati Thaker of FinCocktail, a personal finance guide, aimed for the average working girl to help her demystify and